INVITROPIA is a modern Molecular and Diagnostic Laboratory, a result of the rapid development in the field of Molecular Diagnostics.

It was founded in January 2022 with the aim of developing and providing molecular tests such as that for the diagnosis of Sars Cov-2 (Covid-19) coronavirus, among others, while very often new tests are added that with the aim of more accurate diagnosis for the treatment of diseases.

INVITROPIA is equipped with state-of-the-art equipment, which together with the use of reliable reagents and the daily control by the medical team, are a guarantee for the validity of the results.

INVITROPIA is an integral part of the German company enverque which maintains Molecular / Diagnostic Laboratories in other countries, constantly investing in innovative medical equipment / machines of the latest technology but also in advanced medical software programs.
In addition, the Diagnostic Laboratory performs Rapid Tests for coronavirus Sars Cov-2 (Covid-19) and all other diagnostic tests (Hematological, Biochemical, Microbiological, etc.).

Special emphasis is given to prevention, in accordance with current international protocols and the new data of medical science, through the various Check Up packages offered.
INVITROPIA has a vision to redefine the citizen-patient relationship with the laboratory physician by providing high quality medical services and serving society with respect and professionalism.